252 related articles for article (PubMed ID: 20683418)
21. Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
Martinelli F; Ditto A; Filippi F; Vinti D; Bogani G; Leone Roberti Maggiore U; Evangelista M; Signorelli M; Chiappa V; Lopez S; Somigliana E; Raspagliesi F
Int J Gynecol Cancer; 2021 Mar; 31(3):457-461. PubMed ID: 33649014
[TBL] [Abstract][Full Text] [Related]
22. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization.
Kim WY; Chang SJ; Chang KH; Yoo SC; Ryu HS
Int J Gynaecol Obstet; 2010 May; 109(2):110-2. PubMed ID: 20096835
[TBL] [Abstract][Full Text] [Related]
23. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
Schorge JO; Lea JS; Ashfaq R
J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).
Yahata H; Sonoda K; Yasunaga M; Ohgami T; Kawano Y; Kaneki E; Okugawa K; Kaku T; Kato K
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e50-e53. PubMed ID: 28429457
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome of stage Ia1 squamous cell carcinoma of the uterine cervix and pathological findings of initial conization.
Yoshinaga M; Hamada T; Orita Y; Yoshitomi Shintomo N; Matsuo T; Tsuji T; Tabata K; Douchi T
J Obstet Gynaecol Res; 2011 Nov; 37(11):1645-9. PubMed ID: 21790884
[TBL] [Abstract][Full Text] [Related]
26. Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome.
Hartman CA; Bragança JF; Gurgel MSC; Zeferino LC; Andrade LALA; Teixeira JC
PLoS One; 2021; 16(7):e0253998. PubMed ID: 34283862
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma.
Lee SW; Kim YM; Son WS; You HJ; Kim DY; Kim JH; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(2):209-15. PubMed ID: 19093236
[TBL] [Abstract][Full Text] [Related]
28. Treatment and outcome of stage Ia1 squamous cell carcinoma of the uterine cervix.
Haller H; Krašević M; Mamula O; Brnčić-Fischer A; Eminović S; Manestar M
Int J Gynaecol Obstet; 2011 Apr; 113(1):72-5. PubMed ID: 21315348
[TBL] [Abstract][Full Text] [Related]
29. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
Reynolds EA; Tierney K; Keeney GL; Felix JC; Weaver AL; Roman LD; Cliby WA
Obstet Gynecol; 2010 Nov; 116(5):1150-7. PubMed ID: 20966701
[TBL] [Abstract][Full Text] [Related]
30. Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.
Maneo A; Sideri M; Scambia G; Boveri S; Dell'anna T; Villa M; Parma G; Fagotti A; Fanfani F; Landoni F
Gynecol Oncol; 2011 Dec; 123(3):557-60. PubMed ID: 21907396
[TBL] [Abstract][Full Text] [Related]
31. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
32. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
33. Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.
Qian Q; Yang J; Cao D; You Y; Chen J; Shen K
J Gynecol Oncol; 2014 Oct; 25(4):293-300. PubMed ID: 25142622
[TBL] [Abstract][Full Text] [Related]
34. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
35. Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins.
Itsukaichi M; Kurata H; Matsushita M; Watanabe M; Sekine M; Aoki Y; Tanaka K
Gynecol Oncol; 2003 Aug; 90(2):387-9. PubMed ID: 12893205
[TBL] [Abstract][Full Text] [Related]
36. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
37. Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
Nica A; Marchocki Z; Gien LT; Kupets R; Vicus D; Covens A
Int J Gynecol Cancer; 2021 Mar; 31(3):447-451. PubMed ID: 33649012
[TBL] [Abstract][Full Text] [Related]
38. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
39. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
Sert BM; Kristensen GB; Kleppe A; Dørum A
Gynecol Oncol; 2021 Aug; 162(2):284-291. PubMed ID: 34083029
[TBL] [Abstract][Full Text] [Related]
40. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
